'''Zalospirone''' ('''WY-47,846''') is a [[binding_selectivity|selective]] [[5-HT1A receptor|5-HT<sub>1A</sub>]] [[partial agonist]] of the [[azapirone]] [[chemical class]].<ref>{{cite journal | last1 = Gleeson | first1 = S | last2 = Barrett | first2 = JE | title = 5-HT1A agonist effects on punished responding of squirrel monkeys | journal = Pharmacology, Biochemistry, and Behavior | volume = 37 | issue = 2 | pages = 335–7 | year = 1990 | pmid = 1981937 | doi=10.1016/0091-3057(90)90344-H}}</ref><ref>{{cite journal | last1 = Singh | first1 = A | last2 = Lucki | first2 = I | title = Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors | journal = Neuropharmacology | volume = 32 | issue = 4 | pages = 331–40 | year = 1993 | pmid = 8497336 | doi=10.1016/0028-3908(93)90153-T}}</ref> It was found to be effective in the treatment of [[anxiety]] and [[major depressive disorder|depression]] in [[clinical trial]]s, but a high proportion of subjects dropped out due to [[side effect]]s and development was subsequently never completed.<ref>{{cite journal | last1 = Rickels | first1 = K | last2 = Derivan | first2 = A | last3 = Kunz | first3 = N | last4 = Pallay | first4 = A | last5 = Schweizer | first5 = E | title = Zalospirone in major depression: a placebo-controlled multicenter study | journal = Journal of Clinical Psychopharmacology | volume = 16 | issue = 3 | pages = 212–7 | year = 1996 | pmid = 8784652 | doi = 10.1097/00004714-199606000-00004 }}</ref>
